CAIX-Targeted PET Imaging Scan for Tumor Diagnosis
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This early-stage trial tests a new type of imaging scan (called PET) that uses a special tracer to help doctors see tumors better. The scan targets a protein called CAIX that appears on many cancer cells, which may help with accurate diagnosis and staging.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Have a confirmed or suspected tumor that your doctor recommends imaging for diagnosis or staging
- Blood counts and liver/kidney function within acceptable ranges (your doctor will check this with lab work)
- Normal heart function
- Expected to live at least 12 weeks
- Be able to lie flat for 30 minutes during the scan
- If childbearing age: negative pregnancy test within 7 days before scan, and agreement to use contraception for 3 months after
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special PET/CT scan (called 68Ga-NYM096) to see if it can help find different types of cancer. The scan may help doctors get clearer pictures of where cancer is in your body.
This trial tests a new PET/CT scan that uses a special tracer to find clear cell kidney cancer. If you are scheduled for kidney tumor removal, this scan may help your surgeon see the cancer more clearly before surgery.
This trial tests a new PET scan tracer called [68Ga]Ga-XT771 to see if it can better detect glioblastoma (a type of brain tumor) and clear cell renal cell carcinoma (a type of kidney cancer). If you have one of these cancers, this scan might help your doctor see the tumor more clearly.
This trial uses a special imaging scan (68Ga-C1 PET/CT) to see kidney cancer more clearly. It helps doctors find and understand clear cell renal cell carcinoma, a common type of kidney cancer.
This trial tests a special PET scan that may help doctors see if a complex kidney cyst is cancerous before surgery. It is for people who are already scheduled to have surgery to remove a kidney mass.
This study tests a special imaging agent (89Zr-TLX250) to help doctors see clear cell kidney cancer during PET/CT scans. It is for people in China who have a single small kidney mass and are already scheduled for surgery to remove it.
Hear when a new Kidney Cancers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.